ArticleFrontiers in medicine2025
Patients treated with thinner artificial hair implants: a case series.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Artificial biocompatible hair implants have been developed and clinically evaluated as a solution for hair loss, utilizing various materials and techniques to optimize safety, efficacy, and patient satisfaction. The primary objective of this study was to assess patient satisfaction in individuals affected by alopecia and treated with Biofibre Materials and methods: A total of 15 patients from different ethnicities were enrolled in the study, including 10 male and 5 female individuals. Biocompatible artificial hair with a diameter of 0.08 mm and a length between 160 and 460 mm (Biofibre Results: Biocompatibility was excellent, with no reported allergies or significant "foreign body" skin reactions. Analysis based on the primary effectiveness endpoint revealed a mean score of 3.1 on a 4-point grading scale, where 1 = not satisfied (one patient), 2 = somewhat satisfied (two patients), 3 = satisfied (seven patients), and 4 = very satisfied (five patients). Discussion: The implantation of new, thinner artificial hair fibers represents a valid and safe technique. Tolerability has improved due to the increased softness and elasticity of these fibers. Conclusion: In conclusion, although the sample size is small, the results of this case series confirm the efficacy and safety of the new Biofibre
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.